Astellas' Drug Discovery Strategy: Focus on Oncology

Based on the goal of delivering innovative and reliable pharmaceutical products to cancer patients for whom no effective treatments exist, Astellas is focusing its efforts on a strategy of precision medicine in its drug discovery which is carried out at three research sites with diversity in their r...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanagita, Yutaka, Takenaka, Toichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314323/
https://www.ncbi.nlm.nih.gov/pubmed/22457362
http://dx.doi.org/10.1093/jjco/hys014
_version_ 1782228086382657536
author Yanagita, Yutaka
Takenaka, Toichi
author_facet Yanagita, Yutaka
Takenaka, Toichi
author_sort Yanagita, Yutaka
collection PubMed
description Based on the goal of delivering innovative and reliable pharmaceutical products to cancer patients for whom no effective treatments exist, Astellas is focusing its efforts on a strategy of precision medicine in its drug discovery which is carried out at three research sites with diversity in their research platforms and research styles.
format Online
Article
Text
id pubmed-3314323
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-33143232012-04-01 Astellas' Drug Discovery Strategy: Focus on Oncology Yanagita, Yutaka Takenaka, Toichi Jpn J Clin Oncol Review Articles Based on the goal of delivering innovative and reliable pharmaceutical products to cancer patients for whom no effective treatments exist, Astellas is focusing its efforts on a strategy of precision medicine in its drug discovery which is carried out at three research sites with diversity in their research platforms and research styles. Oxford University Press 2012-04 /pmc/articles/PMC3314323/ /pubmed/22457362 http://dx.doi.org/10.1093/jjco/hys014 Text en © 2012 The Author(s) http://creativecommons.org/licenses/by-nc/2.0/uk/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Articles
Yanagita, Yutaka
Takenaka, Toichi
Astellas' Drug Discovery Strategy: Focus on Oncology
title Astellas' Drug Discovery Strategy: Focus on Oncology
title_full Astellas' Drug Discovery Strategy: Focus on Oncology
title_fullStr Astellas' Drug Discovery Strategy: Focus on Oncology
title_full_unstemmed Astellas' Drug Discovery Strategy: Focus on Oncology
title_short Astellas' Drug Discovery Strategy: Focus on Oncology
title_sort astellas' drug discovery strategy: focus on oncology
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314323/
https://www.ncbi.nlm.nih.gov/pubmed/22457362
http://dx.doi.org/10.1093/jjco/hys014
work_keys_str_mv AT yanagitayutaka astellasdrugdiscoverystrategyfocusononcology
AT takenakatoichi astellasdrugdiscoverystrategyfocusononcology

Ejemplares similares